Covered recipient · General Payments record
ALAN TSENG
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2021–2024
$1,574.64
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $735.03 | 12 |
| Education | $146.69 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $297.08 | 6 |
| PFIZER INC. | $124.99 | 1 |
| GENZYME CORPORATION | $124.88 | 1 |
| SOBI, INC | $114.00 | 1 |
| ABBVIE INC. | $99.99 | 1 |
| Lilly USA, LLC | $46.70 | 1 |
| Astellas Pharma US Inc | $24.89 | 1 |
| Blueprint Medicines Corporation | $24.60 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $99.99 | 09/03/2024 | Education | Undisputed | 01/23/2026 | 1106249393 | CMS |
| Astellas Pharma US Inc | $24.89 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140287565 | CMS |
| Blueprint Medicines Corporation | $24.60 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147446714 | CMS |
| GENZYME CORPORATION | $124.88 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139811474 | CMS |
| Janssen Biotech, Inc. | $148.64 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291841 | CMS |
| Janssen Biotech, Inc. | $15.60 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291863 | CMS |
| Janssen Biotech, Inc. | $44.81 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291821 | CMS |
| Janssen Biotech, Inc. | $43.26 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291873 | CMS |
| Janssen Biotech, Inc. | $30.77 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291921 | CMS |
| Janssen Biotech, Inc. | $14.00 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078291897 | CMS |
| Lilly USA, LLC | $46.70 | 01/10/2024 | Education | Undisputed | 01/23/2026 | 1136014002 | CMS |
| Novartis Pharmaceuticals Corporation | $24.59 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087369870 | CMS |
| PFIZER INC. | $124.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131470148 | CMS |
| SOBI, INC | $114.00 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141408916 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.